Abiopharma

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium’s Dose Strengths in Progressive Multiple Sclerosis

New Form 8-K - Tourmaline Bio, Inc. Filed: 2025-09-09 AccNo: 0001193125-25-198747 Size: 933 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Sintx Technologies, Inc. Filed: 2025-09-09 AccNo: 0001493152-25-012834 Size: 820 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form EFFECT - Immuneering Corp Filed: 2025-09-08 AccNo: 9999999995-25-002880 Size: 1 KB

New Form EFFECT - Autonomix Medical, Inc. Filed: 2025-09-08 AccNo: 9999999995-25-002872 Size: 1 KB

New Form EFFECT - Scinai Immunotherapeutics Ltd. Filed: 2025-09-08 AccNo: 9999999995-25-002864 Size: 1 KB

General Announcement: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS): DEALINGS OUTSIDE CLOSED PERIOD

TRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to Shareholders

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress

FDA approve FUROSEMIDE

FDA approve PHYTONADIONE

NASDAQ symbol attribute type Security_Name was changed. Previous value: Renovaro Inc. - Common Stock. New value: Lunai Bioworks Inc. - Common Stock.

Shareholder Alert: The Ademi Firm investigates whether Tourmaline Bio, Inc. is obtaining a Fair Price for its Public Shareholders

Best Cheap Air Fryers for Healthy Cooking in 2025